Asian Pacific Journal of Cancer Prevention

  • 제15권6호
  • /
  • Pages.2893-2900
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Model-Based Survival Estimates of Female Breast Cancer Data

  • Khan, Hafiz Mohammad Rafiqullah (Department of Biostatistics, Robert Stempel College of Public Health & Social Work, Florida International University) ;
  • Saxena, Anshul (Department of Health Promotion & Disease Prevention, Robert Stempel College of Public Health & Social Work, Florida International University) ;
  • Gabbidon, Kemesha (Department of Health Promotion & Disease Prevention, Robert Stempel College of Public Health & Social Work, Florida International University) ;
  • Rana, Sagar (Division of Research Information and Data Coordinating Center, Florida International University) ;
  • Ahmed, Nasar Uddin (Department of Epidemiology, Robert Stempel College of Public Health & Social Work, Florida International University)
  • 발행 : 2014.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Statistical methods are very important to precisely measure breast cancer patient survival times for healthcare management. Previous studies considered basic statistics to measure survival times without incorporating statistical modeling strategies. The objective of this study was to develop a data-based statistical probability model from the female breast cancer patients' survival times by using the Bayesian approach to predict future inferences of survival times. Materials and Methods: A random sample of 500 female patients was selected from the Surveillance Epidemiology and End Results cancer registry database. For goodness of fit, the standard model building criteria were used. The Bayesian approach is used to obtain the predictive survival times from the data-based Exponentiated Exponential Model. Markov Chain Monte Carlo method was used to obtain the summary results for predictive inference. Results: The highest number of female breast cancer patients was found in California and the lowest in New Mexico. The majority of them were married. The mean (SD) age at diagnosis (in years) was 60.92 (14.92). The mean (SD) survival time (in months) for female patients was 90.33 (83.10). The Exponentiated Exponential Model found better fits for the female survival times compared to the Exponentiated Weibull Model. The Bayesian method is used to obtain predictive inference for future survival times. Conclusions: The findings with the proposed modeling strategy will assist healthcare researchers and providers to precisely predict future survival estimates as the recent growing challenges of analyzing healthcare data have created new demand for model-based survival estimates. The application of Bayesian will produce precise estimates of future survival times.

키워드

참고문헌

  1. American Cancer Society (ACS) (2012). Breast Cancer Facts & Figures 2011-2012. Atlanta: American Cancer Society.
  2. ACS (2013). Cancer Facts and Figures. Atlanta: American Cancer Society.
  3. Ahmed SE, Tomkins RJ (1995). Estimating lognormal mean using uncertain prior information, Pakistan J Statistics, 11, 67-92.
  4. Ahmed SE, Budsaba K, Lisawadi S, Volodin AI (2008). Parametric estimation for the Birnbaum-Saunders lifetime distribution based on a new parameterization, Thailand Statistician, 6, 213-40.
  5. Ahsanullah M, Ahmed SE (2001). Bayes and empirical Bayes estimates of survival and hazard functions of a class of distributions. Lecture Notes in Statistics, 148, 81-7. https://doi.org/10.1007/978-1-4613-0141-7_6
  6. Akaike H (1973). Information theory and an extension of the maximum likelihood principle. N.Petrov and E. Caski (eds), Budhapest: Addademiai Kiado, Proceedings of the 2nd International Symposium on Information Theory.
  7. Baghestani AR, Hajizadeh E, Fatemi SR (2009). Bayesian analysis for survival of patients with gastric cancer in Iran. Asian Pac J Cancer Prev, 10, 823-6.
  8. Barton MK (2013). Potential survival benefit with lumpectomy for patients with early stage breast cancer. CA Cancer J Clin, 63, 217-8. https://doi.org/10.3322/caac.21188
  9. Burstein HJ, Prestrud AA, Seidenfeld J, et al (2010). American Society of Clinical Oncology clinical practice guidelines: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol, 28, 3784-96 https://doi.org/10.1200/JCO.2009.26.3756
  10. Congdon P (2007). Mixtures of spatial and unstructured effects for spatially discontinuous health outcomes. Computational Statistics and Data Analysis, 51, 3197-212. https://doi.org/10.1016/j.csda.2006.11.028
  11. Feigelson HS, James TA, Single RM, et al (2013). Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg, 216, 966-75. https://doi.org/10.1016/j.jamcollsurg.2013.01.011
  12. Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer.
  13. Gampenrieder SP, Rinnerthaler G, Greil R. (2013). Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future. J Oncol, 2013, 732047.
  14. Gilks WR, Richardson S, Spiegelhalter DJ (1996). Markov Chain Monte Carlo in Practice. Chapman & Hall, Suffolk.
  15. Giuliano AE, Hunt KK, Ballman KV, et al (2011). Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA, 305, 569-75. https://doi.org/10.1001/jama.2011.90
  16. Goel S, Gupta N, Walcott BP, et al (2013). Effects of vascularendothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. J Natl Cancer Inst, 105, 1188-201. https://doi.org/10.1093/jnci/djt164
  17. Goldhirsch A, Winer EP, Coates AS, et al (2013). Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol, 24, 2206-23. https://doi.org/10.1093/annonc/mdt303
  18. Graham LJ, Shupe MP, Schneble EJ, et al (2014). Current approaches and challenges in monitoring treatment responses in breast cancer. J Cancer, 5, 58-68. https://doi.org/10.7150/jca.7047
  19. Gupta RD, Kundu D (1999). Generalized exponential distributions. Aust N Z J Stat, 41, 173-88. https://doi.org/10.1111/1467-842X.00072
  20. Gupta RD, Kundu D (2001). Exponentiated exponential family: An alternative to gamma and Weibull distributions. Biometrical J , 43, 117-30. https://doi.org/10.1002/1521-4036(200102)43:1<117::AID-BIMJ117>3.0.CO;2-R
  21. Hou N, Huo D (2013). A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase. Breast Cancer Res Treat, 138, 633-41. https://doi.org/10.1007/s10549-013-2434-0
  22. Jafari-Koshki T, Schmid VJ, Mahaki B (2014). Trends of breast cancer incidence in Iran During 2004-2008: A Bayesian space-time model. Asian Pac J Cancer Prev, 15, 1557-61. https://doi.org/10.7314/APJCP.2014.15.4.1557
  23. Jemal A, Bray F, Center M, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  24. Khatcheressian JL, Hurley P, Bantug E, et al (2013). Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. JCO, 31, 961-65. https://doi.org/10.1200/JCO.2012.45.9859
  25. Khan HMR (2012a). Estimating predictive inference for responses from the generalized rayleigh model based on complete sample, J Thai Statistician, 10, 53-68.
  26. Khan HMR (2012b). Several priors based inference from the exponential model under censoring, JP J Fund Appl Stat, 2, 1-13.
  27. Khan HMR (2012c). Predictive inference for a future response using symmetrically trimmed sample from the half-normal model, Comput Stat Data Anal, 56, 1350-61. https://doi.org/10.1016/j.csda.2011.10.009
  28. Khan HMR (2012d). Improved predictive inference for responses based on location parameter median from the Rayleigh model given a doubly censored sample, Communications in Statistics - Theory and Methods, 41, 4427-38. https://doi.org/10.1080/03610926.2011.574218
  29. Khan HMR (2013a). Comparing relative efficiency from a right skewed model, JP J Biostat, 9, 1-26.
  30. Khan HMR (2013b). Inferential estimates from the oneparameter half-normal model. J Thai Stat, 11, 77-95.
  31. Khan HMR, Albatineh AN, Kheradia TN (2013). Local predictive estimates towards MLEs from the generalized half-normal model. J Stat Adv Theo Appl, 9, 73-98.
  32. Khan HMR, Albatineh AN, Tesfa S, et al (2011a). Predictive inference from two-parameter Weibull model given a doubly censored sample of hepatocellular carcinoma of liver patients, J App Stat Sci, 19, 115-28
  33. Khan HMR, Albatineh A, Alshahrani S, et al (2011b). Sensitivity analysis of predictive modeling for responses from the three-parameter Weibull model with a follow-up doubly censored sample of cancer patients, Comput Stat Data Anal, 55, 3093-103. https://doi.org/10.1016/j.csda.2011.05.017
  34. Khan HMR, Haq MS, Provost SB (2004). Predictive distributions for responses from the Weibull life testing model. J Stat Theory App, 3, 53-73.
  35. Khan HMR, Provost SB, Singh A (2010). Predictive inference from a two parameter Rayleigh life model given a doubly censored sample, Commun Stat Theory Methods, 39, 1237-46. https://doi.org/10.1080/03610920902871453
  36. Khan HM, Saxena A, Rana S, Ahmed NU (2014). Bayesian method for modeling male breast cancer survival data.. Asian Pac J Cancer Prev, 15, 663-9. https://doi.org/10.7314/APJCP.2014.15.2.663
  37. Kleinbaum DG, Klein M. (2012). Survival Analysis: A Self- Learning Text (3rd ed.). New York: Springer.
  38. Kwan ML, Kushi LH, Weltzien E, et al (2010). Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. JCO, 28, 4410-16. https://doi.org/10.1200/JCO.2010.29.2730
  39. Litiere S, Werutsky G, Fentiman IS, et al (2012). Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol, 13, 412-19. https://doi.org/10.1016/S1470-2045(12)70042-6
  40. Liu SZ, Zhang F, Quan PL, et al (2012). Time trends of esophageal cancer mortality in Linzhou city during the period 1988-2010 and a Bayesian approach projection for 2020. Asian Pac J Cancer Prev, 13, 4501-4. https://doi.org/10.7314/APJCP.2012.13.9.4501
  41. Mariotto AB, Yabroff KR, Shao Y, et al (2011). Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst, 103, 117-28. https://doi.org/10.1093/jnci/djq495
  42. Montero AJ, Eapen S, Gorin B, Adler P (2012). The economic burden of metastatic breast cancer: a US managed care perspective. Breast Cancer Res Treat, 134, 815-22. https://doi.org/10.1007/s10549-012-2097-2
  43. MRC Biostatistics Unit (2013). WinBUGS software version 1.4.3: The BUGS Project.
  44. Nassar MM, Eissa FH (2003). On the exponentiated Weibull distribution. Commun Stat Theory Methods, 32, 1317-36. https://doi.org/10.1081/STA-120021561
  45. National Cancer Institute (NCI) (2013). Breast Cancer Treatment ($PDQ^{(R)}$). Health Professional version, updated: November 19, 2013.
  46. Peairs KS, Barone BB, Snyder CF, et al (2011). Diabetes mellitus and breast cancer outcomes: a systematic review and metaanalysis. JCO, 29, 40-6. https://doi.org/10.1200/JCO.2009.27.3011
  47. Protani M, Coory M, Martin JH (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123, 627-35. https://doi.org/10.1007/s10549-010-0990-0
  48. Rao R, Euhus D, Mayo HG, Balch C (2013). Axillary node interventions in breast cancer: a systematic review. JAMA, 310, 1385-94. https://doi.org/10.1001/jama.2013.277804
  49. Robertson C, Arcot Ragupathy SK, Boachie C, et al (2011). The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. Health Technol Assess, 15, 1-322.
  50. Sakamoto Y, Ishiguro M, Kitagawa G (1986). Akaike Information Criterion Statistics. Tokyo: D. Reidel.
  51. SEER (2013). Surveillance, Epidemiology and End Results. Cancer of the Breast - SEER Stat Fact Sheets.
  52. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
  53. Smith RA, Brooks D, Cokkinides V, et al (2013). Cancer screening in the United States, 2013. CA Cancer J Clin, 63, 87-105. https://doi.org/10.3322/caac.21174
  54. Spiegelhalter DJ, Best NG, Carlin BP, Van der Linde A (2002). Bayesian measures of model complexity and fit (with discussion). J R Stat Soc Ser B Stat Methodol, 64, 191-232.
  55. Sprague BL, Trentham Dietz A, Gangnon RE, et al (2011). Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer, 117, 1542-51. https://doi.org/10.1002/cncr.25589
  56. U.S. Cancer Statistics Working Group (USCS). (2013). United States Cancer Statistics: 1999-2010 Incidence and Mortality Web-based Report. Atlanta: U.S. DHHS, CDC and NCI.
  57. Weiner LM, Surana R, Wang S (2010). Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nat Rev Immunol, 10 317-27. https://doi.org/10.1038/nri2744
  58. White A, Richardson LC, Krontiras H, Pisu M (2013). Socioeconomic disparities in breast cancer treatment among older women. J Women's Health.
  59. Wolfram Research (2012). The Mathematica Archive: Mathematica 8.0, Wolfram Research Inc, Illinois.
  60. World Health Organization (WHO) (2013a). Cause-specific mortality and morbidity: Age-standardized mortality rate by cause by World Bank income group, 2008. Geneva: WHO.
  61. WHO (2013b). Charts for the 10 leading causes of death for women worldwide and by income group, 2011. Geneva: WHO.
  62. Yang XR, Chang-Claude J, Goode EL, et al (2011). Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst, 103, 250-63. https://doi.org/10.1093/jnci/djq526
  63. Zurrida S, Bassi F, Arnone P, et al (2011). The changing face of mastectomy (from mutilation to aid to breast reconstruction). Int J Surg Oncol, 2011, 980158.

피인용 문헌

  1. Clinical and Prognostic Significance of SOX11 in Breast Cancer vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5483
  2. Statistical Applications for the Prediction of White Hispanic Breast Cancer Survival vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5571
  3. Health Disparities between Black Hispanic and Black Non-Hispanic Cervical Cancer Cases in the USA vol.15, pp.22, 2014, https://doi.org/10.7314/APJCP.2014.15.22.9719
  4. Survival Analysis for White Non-Hispanic Female Breast Cancer Patients vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.4049
  5. Does Survival Vary for Breast Cancer Patients in the United States? A Study from Six Randomly Selected States vol.2017, pp.1687-9813, 2017, https://doi.org/10.1155/2017/6950579